Labcorp Holdings Operating Expenses Growth & History (LH)
Labcorp Holdings's operating expenses was $2.63B for fiscal 2025.
View full Labcorp Holdings company overviewLabcorp Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.63B | $90.1M | +3.55% |
| 2024 | 2024-12-31 | $2.54B | −$101.6M | −3.85% |
| 2023 | 2023-12-31 | $2.64B | $366.9M | +16.15% |
| 2022 | 2022-12-31 | $2.27B | $328.6M | +16.91% |
| 2021 | 2021-12-31 | $1.94B | −$563.6M | −22.48% |
| 2020 | 2020-12-31 | $2.51B | $585.1M | +30.44% |
| 2019 | 2019-12-31 | $1.92B | $71.6M | +3.87% |
| 2018 | 2018-12-31 | $1.85B | $64.1M | +3.59% |
| 2017 | 2017-12-31 | $1.79B | $203.2M | +12.83% |
| 2016 | 2016-12-31 | $1.58B | −$323.1M | −16.95% |
| 2015 | 2015-12-31 | $1.91B | $613.8M | +47.48% |
| 2014 | 2014-12-31 | $1.29B | $60.4M | +4.90% |
| 2013 | 2013-12-31 | $1.23B | $6.1M | +0.50% |
| 2012 | 2012-12-31 | $1.23B | −$100.1M | −7.55% |
| 2011 | 2011-12-31 | $1.33B | $207.3M | +18.53% |
| 2010 | 2010-12-31 | $1.12B | $84.0M | +8.12% |
| 2009 | 2009-12-31 | $1.03B | $4.1M | +0.40% |
| 2008 | 2008-12-31 | $1.03B | $116.7M | +12.77% |
| 2007 | 2007-12-31 | $914.2M | — | — |
Labcorp Holdings quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $660.4M | $8.7M | +1.33% |
| Q1 2026 | 2026-03-31 | $633.0M | $11.0M | +1.77% |
| Q4 2025 | 2025-12-31 | $725.6M | $45.8M | +6.74% |
| Q3 2025 | 2025-09-30 | $628.5M | −$21.8M | −3.35% |
| Q2 2025 | 2025-06-30 | $651.7M | $20.1M | +3.18% |
| Q1 2025 | 2025-03-31 | $622.0M | $46.0M | +7.99% |
| Q4 2024 | 2024-12-31 | $679.8M | −$264.4M | −28.00% |
| Q3 2024 | 2024-09-30 | $650.3M | $51.4M | +8.58% |
| Q2 2024 | 2024-06-30 | $631.6M | $55.7M | +9.67% |
| Q1 2024 | 2024-03-31 | $576.0M | $55.7M | +10.71% |
| Q4 2023 | 2023-12-31 | $944.2M | $242.7M | +34.60% |
| Q3 2023 | 2023-09-30 | $598.9M | $86.7M | +16.93% |
| Q2 2023 | 2023-06-30 | $575.9M | $62.2M | +12.11% |
| Q1 2023 | 2023-03-31 | $520.3M | −$24.7M | −4.53% |
| Q4 2022 | 2022-12-31 | $701.5M | $478.1M | +214.01% |
| Q3 2022 | 2022-09-30 | $512.2M | −$106.4M | −17.20% |
| Q2 2022 | 2022-06-30 | $513.7M | −$47.0M | −8.38% |
| Q1 2022 | 2022-03-31 | $545.0M | $3.9M | +0.72% |
| Q4 2021 | 2021-12-31 | $223.4M | −$388.3M | −63.48% |
| Q3 2021 | 2021-09-30 | $618.6M | $106.3M | +20.75% |
| Q2 2021 | 2021-06-30 | $560.7M | $97.9M | +21.15% |
| Q1 2021 | 2021-03-31 | $541.1M | −$379.5M | −41.22% |
| Q4 2020 | 2020-12-31 | $611.7M | $127.4M | +26.31% |
| Q3 2020 | 2020-09-30 | $512.3M | $34.9M | +7.31% |
| Q2 2020 | 2020-06-30 | $462.8M | −$26.3M | −5.38% |
| Q1 2020 | 2020-03-31 | $920.6M | $449.1M | +95.25% |
| Q4 2019 | 2019-12-31 | $484.3M | $19.6M | +4.22% |
| Q3 2019 | 2019-09-30 | $477.4M | $30.9M | +6.92% |
| Q2 2019 | 2019-06-30 | $489.1M | $23.2M | +4.98% |
| Q1 2019 | 2019-03-31 | $471.5M | −$2.1M | −0.44% |
| Q4 2018 | 2018-12-31 | $464.7M | −$21.8M | −4.48% |
| Q3 2018 | 2018-09-30 | $446.5M | −$11.0M | −2.40% |
| Q2 2018 | 2018-06-30 | $465.9M | $17.7M | +3.95% |
| Q1 2018 | 2018-03-31 | $473.6M | $79.2M | +20.08% |
| Q4 2017 | 2017-12-31 | $486.5M | $306.6M | +170.43% |
| Q3 2017 | 2017-09-30 | $457.5M | −$6.9M | −1.49% |
| Q2 2017 | 2017-06-30 | $448.2M | −$13.1M | −2.84% |
| Q1 2017 | 2017-03-31 | $394.4M | −$83.4M | −17.46% |
| Q4 2016 | 2016-12-31 | $179.9M | −$327.8M | −64.57% |
| Q3 2016 | 2016-09-30 | $464.4M | $7.6M | +1.66% |
| Q2 2016 | 2016-06-30 | $461.3M | $12.0M | +2.67% |
| Q1 2016 | 2016-03-31 | $477.8M | −$14.9M | −3.02% |
| Q4 2015 | 2015-12-31 | $507.7M | −$520.8M | −50.64% |
| Q3 2015 | 2015-09-30 | $456.8M | $127.0M | +38.51% |
| Q2 2015 | 2015-06-30 | $449.3M | $127.4M | +39.58% |
| Q1 2015 | 2015-03-31 | $492.7M | −$806.1M | −62.06% |
| Q4 2014 | 2014-12-31 | $1.03B | $717.4M | +230.60% |
| Q3 2014 | 2014-09-30 | $329.8M | $26.8M | +8.84% |
| Q2 2014 | 2014-06-30 | $321.9M | $13.9M | +4.51% |
| Q1 2014 | 2014-03-31 | $1.30B | $988.6M | +318.70% |
| Q4 2013 | 2013-12-31 | $311.1M | −$11.6M | −3.59% |
| Q3 2013 | 2013-09-30 | $303.0M | −$8.0M | −2.57% |
| Q2 2013 | 2013-06-30 | $308.0M | $4.5M | +1.48% |
| Q1 2013 | 2013-03-31 | $310.2M | $21.2M | +7.34% |
| Q4 2012 | 2012-12-31 | $322.7M | $20.6M | +6.82% |
| Q3 2012 | 2012-09-30 | $311.0M | −$18.1M | −5.50% |
| Q2 2012 | 2012-06-30 | $303.5M | −$59.0M | −16.28% |
| Q1 2012 | 2012-03-31 | $289.0M | −$43.6M | −13.11% |
| Q4 2011 | 2011-12-31 | $302.1M | $11.3M | +3.89% |
| Q3 2011 | 2011-09-30 | $329.1M | $36.7M | +12.55% |
| Q2 2011 | 2011-06-30 | $362.5M | $99.4M | +37.78% |
| Q1 2011 | 2011-03-31 | $332.6M | $59.9M | +21.97% |
| Q4 2010 | 2010-12-31 | $290.8M | $30.6M | +11.76% |
| Q3 2010 | 2010-09-30 | $292.4M | $29.2M | +11.09% |
| Q2 2010 | 2010-06-30 | $263.1M | $400,000 | +0.15% |
| Q1 2010 | 2010-03-31 | $272.7M | $23.8M | +9.56% |
| Q4 2009 | 2009-12-31 | $260.2M | — | — |
| Q3 2009 | 2009-09-30 | $263.2M | $3.8M | +1.46% |
| Q2 2009 | 2009-06-30 | $262.7M | −$33.9M | −11.43% |
| Q1 2009 | 2009-03-31 | $248.9M | — | — |
| Q3 2008 | 2008-09-30 | $259.4M | — | — |
| Q2 2008 | 2008-06-30 | $296.6M | — | — |
Labcorp Holdings operating expenses trends
Over the last five fiscal years, Labcorp Holdings's operating expenses increased from $2.51B to $2.63B, a change of $120.4M. The latest reported quarter, Q2 2026, shows $660.4M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Labcorp Holdings source filings ↗Community posts
Labcorp sets new medium-term growth targets and reaffirms its annual outlook
Labcorp ($LH) set medium-term targets for annual revenue growth of 5–8% and adjusted earnings-per-share growth of 8.5–11.5% through 2029. The company also reaffirmed its existing 2026 guidance. The new framework describes the performance ma ...
Labcorp acquires MLM Medical Labs to expand clinical-trial services
Labcorp ($LH) acquired MLM Medical Labs, adding central and specialty laboratory operations in the United States, Germany and South Africa. The company said the purchase expands its biomarker-testing capabilities and improves its ability to ...